• Professor of Biomedical Engineering, University of Toronto
  • Senior Scientist, Toronto General Hospital Research Institute, University Health Network
  • Co-Director, Centre for Research and Applications in Fluidic Technologies (CRAFT)
  • Canada Research Chair in Organ-on-a-Chip Engineering

Dr. Milica Radisic is an international leader in the emerging field of tissue engineering and regenerative medicine through her work as a Professor at the University of Toronto’s Institute of Biomaterials and Biomedical Engineering, and Senior Scientist at Toronto General Hospital Research Institute.

Her work on the development of new heart tissue has the potential to significantly improve the quality of life for the estimated 70,000 Canadians who suffer from heart attacks each year. As the first scientist to use electrical stimulation to mimic the beating of a heart during cellular growth, Dr. Radisic discovered a new technique to patch over damaged tissues.

For this important breakthrough, Dr. Radisic has been profiled in numerous publications, including the Toronto Star, Toronto Life, and The Scientist, which proclaimed her as “Scientist to Watch.”

Committed to increasing the enrolment of women in science, technology, engineering, and mathematics (STEM) subjects, Dr. Radisic has participated in various outreach activities to promote opportunities for young women and inspire the next generation of engineers.

Dr. Radisic received her PhD in Chemical Engineering from the Massachusetts Institute of Technology in 2004, after obtaining a B.Eng. from McMaster University in 1999. Prior to joining the University of Toronto in 2005, she was a postdoctoral associate at the Harvard-MIT Division of Health and Science Technology. She is also the Scientific Founder of TARA Biosystems which harnesses innovations in stem cell biology and tissue engineering to generate in vitro biology that recapitulates human physiology. The company was recently acquired by Valo Health a technology company that is using human-centric data and AI to transform the drug discovery and development process.